Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: Effect of immunization with an outer membrane protein vaccine

FEMS Immunology and Medical Microbiology

Volumn 28, Issue 4, 2000, Pages 319-327

  Milagres, Lucimar G ^a   Gorla, Maria Cecília O ^a   Rebelo, Maria Cristina ^b   Barroso, David E ^b  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b Meningitis Reference Laboratory   (Brazil)

Author keywords

Bactericidal antibody response; Neisseria meningitidis; Vaccine

Indexed keywords

MENINGITIS VACCINE; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VA MENGOC BC;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL MENINGITIS; CHILD; CONTROLLED STUDY; CONVALESCENCE; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS; SEROTYPING; VACCINATION;

EID: 0034125140     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00173-5     Document Type: Article

References (28)

1. Tikhomirov E., Santamaria M., Esteves K. Meningococcal disease: public health burden and control. World Health Statist. Quart. 50:1997;170-177.
2. Centro Nacional de Epidemiologia (CENEPI) (1993) Informe epidemiológico do SUS, Ano. II, No. 6. Nov/Dez.
3. Camargo M.C.C., Hidalgo N.T.R. Doença meningocócica: a vacina contra o meningococo B e a situação atual na grande São Paulo. Imunizações. 2:1989;161-167.
4. Sacchi C.T., Pessoa L.L., Ramos S.R., Milagres L.G., Camargo M.C.C., Hidalgo N.T.R., Melles C.E.A., Caugant D.A., Frasch C.E. Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J. Clin. Microbiol. 30:1992;1734-1738.
5. Frasch C.E. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2:1989;S134-S138.
6. Moraes J.C., Perkins B.A., Camargo M.C.C., Hidalgo N.T.R., Barbosa H.A., Sacchi C.T., Gral I.M.L., Gattas V.L., Vasconcelos H.G., Plikaytis B.D., Wenger J.D., Broome C.V. Protective efficacy of a serogroup B meningococcal vaccine in São Paulo. Lancet. 340:1992;1074-1078.
7. Noronha C.P., Baran M., Nicolai C.C.A., Azevedo M.B., Bernardes A.T.O., Monteiro G.T.R., Lopes G.R.S., Rodrigues R.S., Santos A.M., Lemos M.C.F. Epidemiologia da doença meningocócica na cidade do Rio de Janeiro: modificações após vacinação contra os sorogrupos B e C. Cad Saúde Públ. 13:1997;295-303.
8. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1969;1307-1326.
9. Wetzler L.W., Ho Y., Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183:1996;1151-1159.
10. Snapper C.M., Rosas F.R., Kehry M.R., Mond J.J., Wetzler L.M. Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect. Immun. 65:1997;3203-3208.
11. ® against disease caused by serogroup B Neisseria meningitidis. In: Neisseria 1990 (Achtman, M., Kohl, P., Marchal, C., Morelli, G., Seiler, A. and Thiesen, B., Eds.), pp. 129-134. Walter de Gruyter, Berlin.
12. Boslego J., Garcia J., Cruz C., Zollinger W.D., Brandddt B., Ruiz S., Martinez M., Arthhur J., Underwood P., Silva W., Moran E., Hankins W., Gilly J., Mays J. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine. 13:1995;821-829.
13. Rosenqvist E., Høiby E.A., Wedege E., Bryn K., Kolberg J., Klem A., Rønnild E., Bjune G., NøKleby H. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:1995;4642-4652.
14. Wedege E., Høiby E.A., Rosenqvist E., Bjune G. Immune response against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect. Immun. 66:1998;3223-3231.
15. Milagres L.G., Gorla M.C., Sacchi C.T., Rodrigues M.M. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect. Immun. 66:1998;4755-4761.
16. Tommassen J., Vermeij P., Struyve M., Benz R., Poolman J.T. Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58:1990;1355-1359.
17. Maslanka S.E., Gheesling L.L., Libutti D.E., Donaldson K.B.J., Harakeh H.S., Dykes J.K., Arhin F.F., Devi S.J.N., Frasch C.E., Huang J.C., Kriz-Kuzemenska P., Lemmon R.D., Lorange M., peeters C.C.A.M., Quataert S., Tai J.Y., Carlone G.M. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 2:1997;132-137.
18. Guttormsen H.K., Wetzler L.M., Solberg C.O. Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect. Immun. 62:1994;1437-1443.
19. Idänpään-Heikkilä I., Høiby E.A., Chattopadhyay P., Airaksinen U., Michaelsen T.M., Wedege E. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease. J. Med. Microbiol. 43:1995;335-343.
20. Milagres L.G., Ramos S.R., Sacchi C.T., Melles C.E.A., Vieira V.S.D., Sato H., Brito G.S., Moraes J.C., Frasch C.E. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:1994;4419-4424.
21. Pollard A.J., Galassini R., van der Voort E.M.R., Booy R., Langford P., Nadel S., Ison C., Kroll J.S., Poolman J., Levin M. Humoral immune response to Neisseria meningitidis in children. Infect. Immun. 67:1999;2441-2451.
22. Barroso, D.E., Carvalho, D.M., Netto, M.A.C., Santos, O.H.L.R., Nascimento, F. and Werneck, G. (1998) The effect of subcapsular meningococcal vaccine in the prognosis of diseased patients. In: Eleventh International Pathogenic Neisseria Conference (Nassif, X., Quentin-Millet, M.J. and Taha, M.K., Eds.), p. 96. Editions E.D.K., Nice.
23. Tappero J.W., Lagos R., Ballesteros A.M., Plikaytis B., Willians D., Dykes J., Gheesling L.L., Carlone G.M., Høiby E.A., Holst J., Nøkleby H., Rosenqvist E., Sierra G., Campa C., Sotolongo F., Vega J., Garcia J., Herrera P., Poolman J.T., Perkins B.A. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines. J. Am. Med. Assoc. 281:1999;1520-1527.
24. van der Voort E.M.R., van der Ley P., van der Biezen J., George S., Tunnela O., van-Dijken H., Kuipers B., Poolman J.T. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect. Immun. 64:1996;2745-2751.
25. Moran E.E., Brandt B.L., Zollinger W.D. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun. 62:1994;5290-5295.
26. Danelli M.G.M., Alves C.M.A., Bastos R.C., Barroso D.E., Peralta J.M., Frasch C.E. Human immune response to epitopes on the meningococcal outer membrane class 5 protein following infection. FEMS Immunol. Med. Microbiol. 15:1996;159-168.
27. Joiner K.A., Warren K.A., Tam M., Frank M.M. Monoclonal antibodies directed to against gonococcal protein I vary in bactericidal activity. J. Immunol. 134:1985;3411-3419.
28. Griffiss J.M., Brandt B.L., Broud D.D., Goroff D.K., Baker C.J. Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150:1984;71-79.